CTOs on the Move


 
Dthera™ Sciences (OTCQB:DTHR) is the leading digital therapeutic company focusing on the elderly. The San Diego-based, publicly traded company is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them. It has two core products: ReminX™, a commercially available consumer health product for individuals suffering from social isolation and dementia; and DTHR-ALZ, and a development-stage product that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer`s disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.dthera.com
  • 7310 Miramar Road Suite 350
    San Diego, CA USA 92126
  • Phone: 858.215.6360

Executives

Name Title Contact Details

Similar Companies

Rhea Health

Rhea Health is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gillette Canada Company

Gillette Canada Company is a Belmont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Abbott International

Abbott International is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osada

Osada is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Oncology

American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. With more than three decades of expertise in all areas of oncology practice management, AON enables physicians to focus on what matters most – providing the highest quality care for patients. We preserve and protect the sustainability of community oncology for physicians, patients and partners, so practices thrive. Ensure that every American has local access to exceptional cancer care. AON provides comprehensive administrative support and ancillary services that help community oncology practices thrive in an increasingly complex healthcare environment. Our collaborative approach and physician-led model allows practices to maintain local leadership and autonomy. With over three decades of successfully improving and advancing community oncology practices, we have developed a proven business model that allows practices to benefit from our scale and expertise in such critical areas as drug-procurement and payer contracting, as well as practice diversification through central lab and pathology, specialty pharmacy. AON was created and is led by the leadership team responsible for the success of Florida Cancer Specialists & Research Institute, the nation`s largest independent community oncology practice. Our team has vast experience in complex and diverse group practice integration and is able to ensure a smooth and successful transition process for local practices that choose to become a part of the AON.